4LaaKsom,Loman N,Borg A,et al.Cytokeratin5/14-positive breast cancer:true basal phenotype confined to BRCA1 tumors.Mod Pathol,2005,18(10):1321-1328.
5Sotiriou C,Neo SY,Mcshane LM,et al.Breastcancer classification and prognosis based on gene expression profiles from a population-based study.Proc Natl Acad Sci USA,2003,100(18):10393-10398.
6Langerod A,Zhao H,Borgano,et al.TP53 mutation status and gene expression profiles are powerful prognostic markers of breast cancer.Breast Cancer Res,2007,9(3):R30.
7Nielsen TO,Hsu FD,Jensen K,et al.Immuno-histochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma.Clin Cancer Res,2004,10(16):5367-5374.
8Kurt M,Harputluoglu H,Deds,et al.Potential molecular targeted therapies in the management of the basal-like subtype of breast cancer.Breast,2007,16(2):111-112.
9Dontu G,El-Ashry D,wicha MS.Breast cancer,stem/progenitor cells and the estrogen receptor.Trends Endocrinol Metab,2004,15(5):193-197.
10Minn AJ,Gupta GP,Siegel PM,et al.Genes that mediate breast cancer metastasis to lung.Nature,2005,436:518-524.
2International Human Genome Sequencing Consortium. Finishing the euchromatic sequence of the human genome. Nature, 2004, 431 : 931-945.
3Perou CM, Sorlie T, Eisen MB, et al. Molecular portraits of huh'Urn breast tumours. Nature, 2000, 406:747-752.
4Sorlie T, Pereu CM, Tibshirani R, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A, 2001,98 : 10869-10874.
5Sorlie T, Tibshirani R, Parker J, et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sei U S A, 2003, 100: 8418-8423.
6Hu ZY, Fan C, Oh DS, et al. The molecular portraits of breast tumors are conserved across microarray platforms. BMC Genomics, 2006, 7:96.
7Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet, 2005, 365 : 1687-1717.
8Eifel P, Axelson JA, Costa J, et al. National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1-3, 2000. J Natl Cancer Inst, 2001, 93:979-989.
9van't Veer LJ, Dai HY, van de Vijver MJ, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature, 2002, 415:530-536.
10van de Vijver MJ, He YD, van't Veer LJ, et al. A gene- expression signature as a predictor of survival in breast cancer. N Engl J Med, 2002, 347:1999-2009.
